Basic information Safety Supplier Related

TRI-T-BUTYL 1 4 7 10-TETRAAZACYCLODODECA

Basic information Safety Supplier Related

TRI-T-BUTYL 1 4 7 10-TETRAAZACYCLODODECA Basic information

Product Name:
TRI-T-BUTYL 1 4 7 10-TETRAAZACYCLODODECA
Synonyms:
  • TRI-T-BUTYL 1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETATE
  • 1,4,7-Tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane
  • 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic Acid Tri-tert-butyl Ester
  • 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(t-butyl acetate)(DO3A-t-Butyl ester)
  • DO3A-t-Bu-ester(M-130)
  • 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, tris(1,1-diMethylethyl) ester
  • 1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETATE
  • TRI-T-BUTYL 1 4 7 10-TETRAAZACYCLODODECA
CAS:
122555-91-3
MF:
C26H50N4O6
MW:
514.7
EINECS:
635-018-3
Mol File:
122555-91-3.mol
More
Less

TRI-T-BUTYL 1 4 7 10-TETRAAZACYCLODODECA Chemical Properties

Melting point:
181-183℃
Boiling point:
561.6±50.0 °C(Predicted)
Density 
1.022
storage temp. 
under inert gas (nitrogen or Argon) at 2–8 °C
solubility 
Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
form 
Low-Melting Solid
pka
9.57±0.20(Predicted)
color 
White to Off-White
Sensitive 
Hygroscopic
InChI
InChI=1S/C26H50N4O6/c1-24(2,3)34-21(31)18-28-12-10-27-11-13-29(19-22(32)35-25(4,5)6)15-17-30(16-14-28)20-23(33)36-26(7,8)9/h27H,10-20H2,1-9H3
InChIKey
NMHVTLJFPDOJOD-UHFFFAOYSA-N
SMILES
N1(CC(OC(C)(C)C)=O)CCNCCN(CC(OC(C)(C)C)=O)CCN(CC(OC(C)(C)C)=O)CC1
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
36/37/38
Safety Statements 
26
WGK Germany 
3
HS Code 
29339900
More
Less

TRI-T-BUTYL 1 4 7 10-TETRAAZACYCLODODECA Usage And Synthesis

Uses

Tri-tert-butyl 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetate with amide ligands bearing positively charged terbium complexes are used for sensitive detection of NADPH-dependent enzyme activities.

Synthesis

5292-43-3

294-90-6

122555-91-3

Under nitrogen protection, 1,4,7,10-tetraazacyclododecane (1 g, 5.81 mmol) was dissolved in anhydrous acetonitrile (20 ml) and cooled to 0 °C. Sodium bicarbonate (1.464 g, 17.44 mmol) was added to the reaction system under stirring conditions. Subsequently, anhydrous acetonitrile solution (10 ml) of tert-butyl bromoacetate (3.4 g, 17.44 mmol) was slowly added through a dropping funnel over a period of 1 hour. The reaction mixture was continued to be stirred at 0 °C for 3 h, followed by raising to room temperature and stirring for 45 h. The progress of the reaction was monitored by thin layer chromatography (TLC) with the unfolding agent being dichloromethane (DCM): methanol (9:1), and the target product had an Rf value of 0.67. Upon completion of the reaction, the reaction mixture was filtered and the filtrate was concentrated to dryness under reduced pressure. The crude product was purified by silica gel column chromatography with the eluent being dichloromethane solution containing 2% methanol to afford tri-tert-butyl 1,4,7,10-tetraazacyclododecane-1,4,7-triacetate (Compound 2) as a white powder in 83.5% yield.

References

[1] Tetrahedron Letters, 2013, vol. 54, # 8, p. 918 - 920
[2] Tetrahedron Letters, 2009, vol. 50, # 31, p. 4459 - 4462
[3] European Journal of Medicinal Chemistry, 2013, vol. 65, p. 12 - 20
[4] Patent: WO2014/200872, 2014, A1. Location in patent: Page/Page column 73; 77
[5] Organic and Biomolecular Chemistry, 2011, vol. 9, # 5, p. 1591 - 1599

TRI-T-BUTYL 1 4 7 10-TETRAAZACYCLODODECASupplier

Grice Rand (Tianjin) Pharmaceutical Co., Ltd. Gold
Tel
022-83705301 13752403750
Email
2966024760@qq.com
Quzhou AMK BioTech Co., Ltd Gold
Tel
0570-3081766 18357083060
Email
sales@qzamkbio.com
Henan Mengtai Pharmaceutical Technology Co., Ltd Gold
Tel
176345344 7 17634854698
Email
1959525201@qq.com
Shanghai Minhan Pharmaceutical Technology Co., Ltd. Gold
Tel
17612188245
Email
2816925681@qq.com
Nanchang Tianzhen Biotechnology Co., Ltd Gold
Tel
13758194781 13173652190
Email
522013271@qq.com